Multiple Myeloma

>

test

Latest News

Teclistamab Provides a Superior Response for Patients with R/R Multiple Myeloma
Teclistamab Provides a Superior Response for Patients with R/R Multiple Myeloma

March 21st 2023

During a Targeted Oncology™ Case-Based Roundtable™ event, Rafael Fonseca, MD, discusses the efficacy and safety with teclistamab for patients with relapsed/refractory multiple myeloma.

BOSTON Trial Shows Efficacy of Selinexor in R/R Multiple Myeloma
BOSTON Trial Shows Efficacy of Selinexor in R/R Multiple Myeloma

March 20th 2023

BCMA Therapies Changing Treatment in Relapsed/Refractory Multiple Myeloma
BCMA Therapies Changing Treatment in Relapsed/Refractory Multiple Myeloma

March 16th 2023

Multiple Myeloma Awareness Month: Advancing The Understanding of Targeted Therapies Role
Multiple Myeloma Awareness Month: Advancing The Understanding of Targeted Therapies Role

March 14th 2023

Next-Line Therapy Choices in R/R Multiple Myeloma After VRd Plus ASCT

March 13th 2023

Video Series
Video Interviews

More News